Related Experiment Video

Updated: Jul 9, 2025

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.8K

Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants

Karen Y He1, Ekaterina A Khramtsova2, Alfredo Cabrera-Socorro3

  • 1Population Analytics & Insights, Data Science Analytics & Insights, Janssen R&D, Spring House, PA, USA. KHe2@ITS.JNJ.com.

Molecular Neurodegeneration
|November 29, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
APOE-Christchurch variantAlzheimer’s diseaseRare variants

More Related Videos

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.8K
Human Adipose Tissue Micro-fragmentation for Cell Phenotyping and Secretome Characterization09:14

Human Adipose Tissue Micro-fragmentation for Cell Phenotyping and Secretome Characterization

Published on: October 20, 2019

9.8K

Related Concept Videos